Additionally, SKP2 was found to be associated with specific signaling pathways (e.g., “complement and coagulation cascades,” “cytokine–cytokine receptor interaction,” and “metabolism of xenobiotics by cytochrome P450”) in at least two cancers (Supplementary Material 16), which required further experimental investigation. This evidence concerns the gene SKP2 and cancer.